ARTICLES BY THIS AUTHOR
- 6/1/2021
Hy-Vee offering COVID-19 vaccine incentives
The retailer is offering a $10 gift card to those who complete their COVID-19 vaccination at one of its pharmacies or pop-up vaccination clinics. - 6/1/2021
Glenmark intros generic Banzel
Banzel tablets had a market value of $285.3 million for the 12-month period ended April 2021, according to IQVIA. - 6/1/2021
Alkermes receives FDA nod for Lybalvi
Alkermes' Lybalvi provides a treatment for adults with certain mental disorders, including schizophrenia and bipolar I. - 6/1/2021
Hikma debuts labetalol hydrochloride in dextrose injection, sodium chloride injection
Labetalol HCl injection, 100 mg/20 ml and 200 mg/40 ml vial had a market value of approximately $6 million in the 12 months ended March 2021, according to IQVIA. - 5/28/2021
Kroger launches $5M giveaway to encourage COVID-19 vaccinations
Kroger’s giveaway, starting next week, will give people who have received their vaccine from Kroger Health a shot at winning one of five $1 million payouts totaling $5 million in cash prizes and a chance to win free groceries for a year. - 5/28/2021
FDA clears preventive indication for Nurtec ODT
This new approval makes Nurtec ODT the first oral CGRP antagonist approved for the preventive treatment of migraine, and the only migraine medication approved as a dual therapy for both the acute and preventive treatment. - 5/27/2021
Upsher-Smith, Rafarm intro generic Vigamox
The moxifloxacin ophthalmic solution had a market value of approximately $34 million for the 12 months ended March 2021, according to IQVIA. - 5/28/2021
Foresee Pharmaceuticals receives FDA nod for Camcevi
Camcevi 42 mg subcutaneous injection is a gonadotropin-releasing hormone agonist indicated for the treatment of adult patients with advanced prostate cancer. - 5/27/2021
FDA grants emergency use authorization for GSK’s COVID-19 treatment
The authorization allows Sotrovimab to be distributed and administered as a 500 mg single dose intravenously by healthcare providers.